Name | breast cancer, hereditary |
Categories | genetic test |
Specimen requirements | 1 ml of EDTA blood |
Procedure remarks | genetic test The patient’s consent is required to carry out genetic tests. |
Clinical utility | suspicions of a family predisposition in high-risk families |
Methodology | PCR and fluorescence-based conformation sensitive gel electrophoresis (F-CSGE) and subsequent analysis with ABI automated sequencerMutation screening in the entire BRCA1 and BRCA2 gene incl. deletion test |
Remarks | Testing currently takes place in a contract laboratory |